Hepatic T1-time, cardiac structure and function and cardiovascular outcomes in patients with dilated cardiomyopathy-Reference-Cited by-同舟云学术

Hepatic T1-time, cardiac structure and function and cardiovascular outcomes in patients with dilated cardiomyopathy

Published:2024-09 Issue: Volume:127 Page:84-90
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Inciardi Riccardo M.^ORCID,Merlo Marco,Bellicini Mariagiulia,Setti Martina^ORCID,De Luca Antonio^ORCID,Di Meo Nunzia,Rondi Paolo^ORCID,Pagnesi Matteo^ORCID,Adamo Marianna,Lombardi Carlo M.,Rizzi Jacopo Giulio^ORCID,Farina Davide,Mantovani Alessandro,Targher Giovanni,Sinagra Gianfranco^ORCID,Metra Marco^ORCID,Arabia Gianmarco,Iseppi Manuela,Gavazzi Emanuele,Lupi Laura,Tomasoni Daniela,Vizzardi Enrico

Publisher

Elsevier BV

Reference28 articles.

1. Circulating markers of liver function and cardiovascular disease risk;Targher;Arterioscler Thromb Vasc Biol,2015

2. Risk of heart failure in patients with nonalcoholic fatty liver disease: JACC review topic of the week;Mantovani;J Am Coll Cardiol,2022

3. The EASL-lancet liver commission: protecting the next generation of Europeans against liver disease complications and premature mortality;Karlsen;Lancet,2022

4. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review;Younossi;Hepatology,2023

5. Bi-directional analysis between fatty liver and cardiovascular disease risk factors;Ma;J Hepatol,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Native skeletal muscle T1-time on cardiac magnetic resonance: A predictor of outcome in patients with heart failure with preserved ejection fraction;European Journal of Internal Medicine;2024-07